ACTIVE

DR. GHIJSELS ERIK, NEFROLOOG

Export PDF

Financial year 2025 · Closed on 30/06/2025

Net result281,2 k €-25,1 %over 1 year
Gross margin461,1 k €-20,6 %over 1 year
Equity99,4 k €-90,2 %over 1 year

Identity

Source · BCE/KBO

DR. GHIJSELS ERIK, NEFROLOOG is a Private limited company incorporated in 2006. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Affligem.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0883.526.082
Incorporation
31/08/2006
Legal form
Private limited company
Registered office
Oudebaan 48
1790 Affligem · FlandreSee on map
Contributed capital
98 580,00 €
Latest accounts
30/06/2025
Signals
ProfitablePositive cashflowPositive EBITDA

Financials

Source · NBB, 18 filings

Trend over 18 financial years

20252024202320222021
Income statement
Gross margin461,1 k €580,9 k €463,1 k €380,9 k €421,9 k €
EBITDA459 k €578,7 k €440,5 k €299,5 k €418,8 k €
Operating result386,5 k €507,8 k €369,4 k €232 k €351,8 k €
Net result281,2 k €375,2 k €296,9 k €150 k €263 k €
Balance sheet
Equity99,4 k €1 M €1 M €957,6 k €1,3 M €
Total assets1,2 M €1,2 M €1,3 M €1,7 M €1,7 M €
Cash252,2 k €172,1 k €191,4 k €231,3 k €171 k €
Debts1,1 M €177,3 k €299,4 k €693,9 k €372,7 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 1 ended

Active mandates

Erik GHIJSELS

Director · since 14 septembre 2006

Active

Ended mandates

Erik GHIJSELS

Manager · since 14 septembre 2006

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date15/01/202629/01/202530/01/202401/02/202331/01/202221/12/2020
General meeting19/12/202530/12/202430/12/202329/12/202223/12/202104/12/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 18 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model30/06/202519/12/202515/01/2026DutchPDF
Micro model30/06/202430/12/202429/01/2025DutchPDF
Abridged model30/06/202330/12/202330/01/2024DutchPDF
Abridged model30/06/202229/12/202201/02/2023DutchPDF
Abridged model30/06/202123/12/202131/01/2022DutchPDF
Abridged model30/06/202004/12/202021/12/2020DutchPDF
Abridged model30/06/201906/12/201907/01/2020DutchPDF
Abridged model30/06/201827/12/201801/02/2019DutchPDF
Abridged model30/06/201701/12/201721/12/2017DutchPDF
Abridged model30/06/201602/12/201612/01/2017DutchPDF
Abridged model30/06/201504/12/201508/01/2016DutchPDF
Abridged model30/06/201405/12/201409/01/2015DutchPDF
Abridged model30/06/201326/12/201320/01/2014DutchPDF
Abridged model30/06/201231/01/201319/02/2013DutchPDF
Abridged model30/06/201130/12/201115/02/2012DutchPDF
Abridged model30/06/201031/12/201028/02/2011DutchPDF
Abridged model30/06/200931/12/200915/02/2010DutchPDF
Abridged model30/06/200805/12/200817/02/2009DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

1 active · 1 ended

Active mandates

Erik GHIJSELS

Director · since 14 septembre 2006

Active

Ended mandates

Erik GHIJSELS

Manager · since 14 septembre 2006

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates11/05/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - BENAMING - ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office08/01/2016
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Capital / shares20/08/2014
    KAPITAAL - AANDELEN
    PDF
  • Other06/06/2007
    BOEKJAAR
    PDF
  • Other11/12/2006
    DIVERSEN
    PDF
  • Other22/09/2006
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025281,2 k €↓
  2. 2024
    Annual accounts 2024375,2 k €↑
  3. 2024
    Name changeDr. GHIJSELS ERIK, NEFROLOOG
  4. 2023
    Annual accounts 2023296,9 k €↑
  5. 2022
    Annual accounts 2022150 k €↓
  6. 2022
    Name changeDr. GHIJSELS Erik
  7. 2021
    Annual accounts 2021263 k €↑
  8. 2020
    Annual accounts 2020221,5 k €↑
  9. 2019
    Annual accounts 2019220,3 k €↑
  10. 2018
    Annual accounts 2018150,3 k €↓
  11. 2017
    Annual accounts 2017222,5 k €↑
  12. 2016
    Annual accounts 2016137,2 k €↓
  13. 2015
    Annual accounts 2015234,8 k €↓
  14. 2014
    Annual accounts 2014264,3 k €↓
  15. 2013
    Annual accounts 2013292,9 k €↑
  16. 2012
    Annual accounts 2012262,6 k €↓
  17. 2011
    Annual accounts 2011350,6 k €↑
  18. 2010
    Annual accounts 2010331,5 k €↑
  19. 2009
    Annual accounts 2009139,6 k €↓
  20. 2008
    Annual accounts 2008271,8 k €
  21. 31/08/2006
    IncorporationPrivate limited company